Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Bone Remodeling01:40

Bone Remodeling

40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
What is the Skeletal System?01:02

What is the Skeletal System?

56.6K
Overview
56.6K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

5.0K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Prevalence and risk factors for falls in older men and women: The English Longitudinal Study of Ageing.

Age and ageing·2016
Same author

Recent advances in the pathogenesis and treatment of osteoporosis.

Clinical medicine (London, England)·2016
Same author

A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Archives of osteoporosis·2016
Same author

On epidemiology of fractures and variation with age and ethnicity.

Bone·2016
Same author

Pubertal timing and bone phenotype in early old age: findings from a British birth cohort study.

International journal of epidemiology·2016
Same author

Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2016
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

オステオポロシス (骨粗鬆症) について

Philip Sambrook1, Cyrus Cooper

  • 1Institute of Bone and Joint Research, University of Sydney, Sydney 2065, NSW, Australia. sambrook@med.usyd.edu.au

Lancet (London, England)
|June 20, 2006
PubMed
まとめ
この要約は機械生成です。

骨粗鬆症の管理は進歩しており,絶対的な骨折リスク評価と骨転移マーカーのより広範な使用へと移行しています. ビスホスフォネートは依然として重要なもので,最適な治療期間と新しい生物学的薬剤に関する研究が進行中です.

関連する実験動画

科学分野:

  • エンドクリノロジー エンドクリノロジー
  • ゲロントロジーはゲロントロジーの学科です.
  • 公衆衛生は公衆衛生である.

背景:

  • 骨粗鬆症は,世界的な健康上の重大な懸念を代表しています.
  • 近年では,骨粗鬆症の流行病学,病理生理学,治療方法の理解に大きな進展がみられた.
  • 継続的な進歩が急速にこの分野を形作っています.

研究 の 目的:

  • 骨粗鬆症の診断と治療の発展の状況をレビューする.
  • 臨床評価と治療戦略における予想される変化を強調する.

主な方法:

  • 骨粗鬆症に関する最近の文献と臨床実践の動向のレビュー.
  • 新興の診断ツールと治療薬の分析.

主要な成果:

  • 臨床的評価は,骨密度計のみから,絶対的な骨折リスクを含むアルゴリズムに移行する可能性が高い.
  • 骨の循環の生化学的マーカーは,より広範な臨床応用を得ることが期待されています.
  • ビスホスフォネートは,抑制レベルと治療期間を最適化することに重点を置いた主要な治療法として残ると予想されています.

結論:

  • 将来の骨粗鬆症のケアには,先進的なリスク評価ツールと,生物学的薬を含む新しい治療法が統合される可能性が高い.
  • 継続的な研究は,治療戦略を洗練し,最適な治療期間と強度を理解するために不可欠です.